Skip to main content

Altasciences

Research Services

Contract research organization specialized in seamless, end-to-end, early phase drug development, we act to get your most promising compounds into and through early phase clinical trials.

Is Altasciences hiring?

Yes. As of November 5, 2026, Altasciences has 189 open roles on Metaintro. 89 were posted in the last 30 days.

Open roles

Newest first. Pay shown when the posting lists it.

Hiring pattern

How fast Altasciences is adding roles, and how they're set up.

New roles each monthRoles first posted in the month

28
105
0
212
12
JulyAugustSeptemberOctoberNovember
November: 12 new roles.

How roles are set upShare of open roles

6%
9%
76%
9%
HybridRemoteOn-siteNot stated
15% of roles are hybrid or remote.

Customers

All 19 companies Altasciences names as customers.

Customers19

  • Ethypharm
  • IDENIX
  • gIcare pharma inc
  • Clinical Operations, Idenix, a wholly-owned subsidiary of Merck & Company
  • Alliance Management Ionis Pharmaceuticals, Inc
  • Tetra Bio-Pharma
  • Locemia Solutions ULC
  • Isis Pharmaceuticals, Inc.
  • Emyria Ltd.
  • Chondrial Therapeutics Inc.
  • Aristea Therapeutics
  • Appili Therapeutics Inc.
  • NeuroTrauma Sciences, LLC
  • Isis Ionis Pharmaceuticals
  • Locemia Solutions
  • Appili Therapeutics
  • Chondrial
  • Aristea testimonial
  • Emyria

What their customers say

Quotes from people at Altasciences's customers.

“We have been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants.”

Hélène Dulude

“...the communication between our teams was optimal, from the first protocol draft to the delivery of final report.”

Maxime Ranger · President and CEO · gIcare pharma inc

“I recommend this site because of the expertise and quality of trials performed.”

Okba Haj-Ali Saflo

“It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions.”

Marie-Françoise Temam · Associate Director · Clinical Operations, Idenix, a wholly-owned subsidiary of Merck & Company

“I … commend Altasciences on their scientific knowledge, efficient and timely processes, and excellent customer service.”

R. Brent Miller
Show 25 more quotes

“…an important partner in our development efforts and we recommend them for any ligand-binding requirements.”

Bryan Tayefeh · Assistant Director · Alliance Management Ionis Pharmaceuticals, Inc

“Algorithme Pharma (now Altasciences) has distinguished itself by their very timely responses to request for proposals, protocol development and study execution. They have consistently delivered complete and very well written study reports on time and in compliance with regulatory expectations. We have been impressed and appreciative of the ongoing assistance and scientific guidance and with the remarkable courtesy and professionalism of their entire staff. We have also been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants.”

Hélène Dulude · Ph.D. Director, Clinical Development · Locemia Solutions ULC

“We have retained the services of Algorithme Pharma (now Altasciences) since 2011 to perform a series of studies ranging from Phase I to Phase III. Consequently, the study populations requested varied from healthy volunteers to populations with a specific disorder such as healthy volunteers suffering from common cold and persons with type 1 or type 2 diabetes (to address our needs). Although Algorithme Pharma (now Altasciences) has traditionally focused on early stage clinical research, they have clearly shown their ability to recruit for and conduct Phase II and Phase III studies.”

Hélène Dulude · Ph.D. Director, Clinical Development · Locemia Solutions ULC

“I am writing to recommend the services of Algorithme Pharma (now Altasciences), with whom Isis Pharmaceuticals Inc. (now Ionis) have partnered to conduct ultrafiltration protein binding, multiplexing through an innovative platform, and quantitative Hybridization ELISA assays for concentration determination. Several matrices in various species were assayed, including Plasma, Brain, Spinal Cord, Liver, Kidney and Ocular tissues.”

Bryan Tayefeh · Assistant Director Alliance Management · Isis Pharmaceuticals, Inc.

“The team members from Algorithme Pharma (now Altasciences) were responsive, hard-working and client oriented. It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions.”

Marie-Françoise TEMAM · Associate Director, Clinical Operations · IDENIX

“I feel confident in recommending Algorithme Pharma (now Altasciences) services.”

Marie-Françoise TEMAM · Associate Director, Clinical Operations · IDENIX

“They did an excellent job for this study: they were the 2nd better recruiter of HCV-infected subjects among 6 sites worldwide, always very transparent in their communication and with a focus on the quality.”

Marie-Françoise TEMAM · Associate Director, Clinical Operations · IDENIX

“I am writing to recommend the services of Algorithme Pharma (now Altasciences).”

Marie-Françoise TEMAM · Associate Director, Clinical Operations · IDENIX

“Finally, the communication between our teams was optimal, from the first protocol draft to the delivery of final report. I would recommend Algorithme Pharma (now Altasciences) to start-up biotechnology companies such as ours, for both first-in-man trials and customized Proofof- Concept trials, such as our barostat study.”

gIcare pharma inc

“This trial was the largest ever barostat study conducted (90 subjects) within the shortest timeframe (3 months). All operations relied on consistency and methodology, and Algorithme Pharma (now Altasciences) delivered the work beyond our expectations. Furthermore, subject recruitment is one of their great assets, and enabled us to complete the study within our corporate timelines.”

gIcare pharma inc

“We needed to conduct a technical Phase 1b study, which involved rectal barostat experiments. Algorithme Pharma’s team was open to put in place and acquire the expertise required to conduct such a large barostat study. They have demonstrated their ability and willingness to adapt their services to meet our needs.”

gIcare pharma inc

“Algorithme Pharma (now Altasciences) has been a great partner for us, in the context of key clinical trials for our lead drug candidates. The professionalism and skills of Algorithme Pharma’s staff were crucial to the success of our Gastrointestinal Phase Ib efficacy program, which included food effect and PK evaluations. Their services were delivered as planned, with time and cost efficiencies. Their expertise in bioanalytical development and method validation has proven to be an added value for our small company.”

gIcare pharma inc

“I feel confident in recommending Algorithme Pharma (now Altasciences) for similar studies.”

Audrey Pechberty · Nonclinical and Pharmacokinetics Unit Manager · Ethypharm

“The team members from Algorithme Pharma (now Altasciences) were responsive, accommodating and hardworking at all times. We truly value our relationship with Algorithme Pharma (now Altasciences) and consider them an important partner in our development efforts.”

Audrey Pechberty · Nonclinical and Pharmacokinetics Unit Manager · Ethypharm

“Algorithme Pharma (now Altasciences) has been a great partner of ours over the years, in performing Phase I studies in healthy volunteers. Recently, we entrusted them with a pharmacokinetic study involving hepatic-impaired subjects (Child Pugh A to C) and healthy volunteers. This study was completed within 10 months, to our satisfaction.”

Audrey Pechberty · Nonclinical and Pharmacokinetics Unit Manager · Ethypharm

“The collaborative approach of the Altasciences experts with our Chondrial team was essential to the success of this project. We appreciate the dedication and hard work of the Altasciences team – it was clear that they never lost sight of our goal to successfully and efficiently develop a product to help patients. We look forward to continuing our work with the Altasciences team towards this important goal.”

David Bettoun, Ph.D. · Vice President Discovery and Preclinical Development · Chondrial Therapeutics Inc.

“We were very pleased with the way the team at Altasciences negotiated the challenges encountered during the bioanalytical development of our complex compound as part of our IND-enabling package. The scientific excellence applied, and the adaptability demonstrated, allowed for successful development of our bioanalytical methods.”

David Bettoun, Ph.D. · Vice President Discovery and Preclinical Development · Chondrial Therapeutics Inc.

“Our experience working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.”

James M. Mackay · President and Chief Executive Officer · Aristea Therapeutics

“The devotion, expertise, and degree of professionalism employed by the team in all stages of development, and the support provided during the Clinical trial, were unprecedented. It was a wonderful experience working with this lab on this novel technique; we appreciate the expertise they provide in this niche environment.”

Appili Therapeutics Inc.

“Altasciences is an important Vendor, providing us with the laboratory services we need to keep our development programs on track.”

R. Brent Miller, Ph.D., PMP · Vice President, Product & Portfolio Development · NeuroTrauma Sciences, LLC

“I am writing to commend Altasciences on their scientific knowledge, efficient and timely processes, and excellent customer service . NeuroTrauma Sciences, LLC has worked with Altasciences to provide bioanalyticallaboratory services for our pre-clinical clinical and clinical programs.”

R. Brent Miller, Ph.D., PMP · Vice President, Product & Portfolio Development · NeuroTrauma Sciences, LLC

“We have thoroughly enjoyed our relationship with Algorithme and consider them an important partner in our development efforts. We would highly recommend Algorithme Pharma to anyone that needs help with their clinical program.”

Hélène Dulude · Director, Clinical Development · Locemia Solutions ULC

“Algorithme Pharma has repeatedly demonstrated a willingness to explore new areas and incorporate tools and technologies to execute new study designs. For example, they have embraced complicated protocols including using insulin to induce hypoglycemia and have welcomed outside expertise to help them further develop internal capabilities.”

Hélène Dulude · Director, Clinical Development · Locemia Solutions ULC

“Algorithme Pharma has distinguished itself by their very timely responses to request for proposals, protocol development and study execution. They have consistently delivered complete and very well written study reports on time and in compliance with regulatory expectations. We have been impressed and appreciative of the ongoing assistance and scientific guidance and with the remarkable courtesy and professionalism of their entire staff. We have also been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants.”

Hélène Dulude · Director, Clinical Development · Locemia Solutions ULC

“We have retained the services of Algorithme Pharma since 2011 to perform a series of studies ranging from Phase I to Phase III. Consequently, the study populations requested varied from healthy volunteers to populations with a specific disorder such as healthy volunteers suffering from common cold and persons with type 1 or type 2 diabetes (to address our needs). Although Algorithme Pharma has traditionally focused on early stage clinical research, they have clearly shown their ability to recruit for and conduct Phase II and Phase III studies.”

Hélène Dulude · Director, Clinical Development · Locemia Solutions ULC

AI launches and partners

What Altasciences has launched and who it works with on AI.

  • OperationsAI in Drug DevelopmentAltasciences states it is committed to using AI to elevate its people, empower its clients, and transform decision-making in drug research.

Skills they ask for

Most frequent across open postings.

Most requested skills

  • Microsoft Office
  • Communication
  • GLP compliance
  • Bilingual communication
  • Customer service
  • Attention to detail
  • GCP compliance
  • MS Office
  • Quality control
  • Animal handling
  • GCP
  • Confidentiality

Tech stack

Analytics
Google Analytics 4
Google Tag Manager
Security
CookieYes
OneTrust
Libraries
Bootstrap
Swiper
CDN
unpkg
CMS
Drupal

Company facts

Headquarters
Laval, Canada
Founded
1992
Industry
Research Services
Sector (NAICS)
Professional, Scientific, and Technical Services
Peer
The businesses of Merck KGaA, Darmstadt, Germany

Roles by location

Where Altasciences is hiring. Pick a city to see its roles.

Similar companies

Companies in the same industry as Altasciences that are hiring now.

Questions about Altasciences

Is Altasciences hiring?
Yes. As of November 5, 2026, Altasciences has 189 open roles on Metaintro. 89 were posted in the last 30 days. The most are in Healthcare/Medical (54), Science, Technology, Engineering, and Math (38), and Biotechnology and Pharmaceuticals (29).
Where is Altasciences hiring?
Altasciences is hiring in Laval, Everett, Columbia, Montreal, Overland Park, and Lower Salford Township, with the most open roles in Laval.
Does Altasciences offer remote or hybrid work?
6% of open roles are hybrid and 9% are remote.
Who are Altasciences's customers?
Altasciences names 19 customers, including Ethypharm, IDENIX, gIcare pharma inc, Clinical Operations, Idenix, a wholly-owned subsidiary of Merck & Company, and Alliance Management Ionis Pharmaceuticals, Inc.
What skills does Altasciences look for?
Its open roles most often ask for Microsoft Office, Communication, GLP compliance, Bilingual communication, and Customer service.
Return to navigation